Freestone Grove Partners »

Vaxcyte shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 225k 58.11
2025-06-30 $210k 6.5k 32.51

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte